Market Cap (In INR)
7.77 Billion
Revenue (In INR)
3.35 Billion
Net Income (In INR)
-230.59 Million
Avg. Volume
39.54 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 390.0-398.65
- PE
- 21.51
- EPS
- 12.28
- Beta Value
- 0.32443863
- ISIN
- INE225B01021
- CUSIP
- -
- CIK
- -
- Shares
- 29431000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Prashant Nagre
- Employee Count
- -
- Website
- http://www.fermentabiotech.com
- Ipo Date
- Details
- Fermenta Biotech Ltd. engages in the manufacturing and supply of Vitamin D3. It produces a range of variants such as crystalline, oil, resin in oil, cold water dispersible (CWD) and feed grade powder, which can be used in applications like injectables, soft gel capsules, premixes, as well as food and beverage fortification. The firm operates through the following segments: Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment engages in manufacturing and selling of chemicals, Drugs and enzymes. The property segment engages in renting of properties. The company was founded by Vijay Kumar Raju Datla on May 1, 1951 and is headquartered in Mumbai, India.
More Stocks
-
002771
-
CGT
-
0OFPNCC AB (publ)
0OFP
-
SIRCA
-
CENTEXTCentury Extrusions Limited
CENTEXT
-
FNEC
-
SAUMYASaumya Consultants Limited
SAUMYA
-
DMEHF